title: Mouse prion protein polymorphism Phe-108/Val-189 affects the kinetics of fibril formation and the response to seeding: evidence for a two-step nucleation polymerization mechanism.
abstract: Prion diseases are fatal neurodegenerative disorders associated with the polymerization of the cellular form of prion protein (PrP(C)) into an amyloidogenic β-sheet infectious form (PrP(Sc)). The sequence of host PrP is the major determinant of host prion disease susceptibility. In mice, the presence of allele a (Prnp(a), encoding the polymorphism Leu-108/Thr-189) or b (Prnp(b), Phe-108/Val-189) is associated with short or long incubation times, respectively, following infection with PrP(Sc). The molecular bases linking PrP sequence, infection susceptibility, and convertibility of PrP(C) into PrP(Sc) remain unclear. Here we show that recombinant PrP(a) and PrP(b) aggregate and respond to seeding differently in vitro. Our kinetic studies reveal differences during the nucleation phase of the aggregation process, where PrP(b) exhibits a longer lag phase that cannot be completely eliminated by seeding the reaction with preformed fibrils. Additionally, PrP(b) is more prone to propagate features of the seeds, as demonstrated by conformational stability and electron microscopy studies of the formed fibrils. We propose a model of polymerization to explain how the polymorphisms at positions 108 and 189 produce the phenotypes seen in vivo. This model also provides insight into phenomena such as species barrier and prion strain generation, two phenomena also influenced by the primary structure of PrP.
authors.affiliation: Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta T6G 2M8, Canada.
authors.forename: Leonardo M
authors.initials: LM
authors.lastname: Cortez
authors.forename: Jitendra
authors.initials: J
authors.lastname: Kumar
authors.forename: Ludovic
authors.initials: L
authors.lastname: Renault
authors.forename: Howard S
authors.initials: HS
authors.lastname: Young
authors.forename: Valerie L
authors.initials: VL
authors.lastname: Sim
mesh_terms: D000483:Alleles; D000818:Animals; D052160:Benzothiazoles; D002942:Circular Dichroism; D004305:Dose-Response Relationship, Drug; D007700:Kinetics; D051379:Mice; D008854:Microscopy, Electron / Q000379:methods; D010649:Phenylalanine / Q000235:genetics*; D011108:Polymers / Q000737:chemistry; D011110:Polymorphism, Genetic; D017096:Prion Diseases / Q000235:genetics / Q000378:metabolism*; D011328:Prions / Q000235:genetics*; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000378:metabolism; D013844:Thiazoles / Q000737:chemistry; D013997:Time Factors; D014633:Valine / Q000235:genetics*
chemical_list: D052160:Benzothiazoles; D011108:Polymers; D011328:Prions; D011994:Recombinant Proteins; D013844:Thiazoles; C009462:thioflavin T; D010649:Phenylalanine; D014633:Valine